EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Integrated Computer-Aided Drug Design: Advances in GPCR Natural Ligand Discovery

Abdullahi Ibrahim Uba

Cell Biochemistry and Biophysics · 2025

DOI: 10.1007/s12013-025-01902-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Abdullahi Ibrahim Uba. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Istanbul AREL University, Istanbul, 34537, Turkey. abdullahiibrahimuba@arel.edu.tr. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Drug Design, Computer-Aided Design, Biological Products. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 209 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G protein-coupled receptors (GPCRs) are the largest and most pharmacologically important family of membrane proteins, responsible for a wide range of physiological responses through the transmission of extracellular signals. Their vital role in human health makes them key targets, with many approved drugs acting by modulating GPCRs. Natural products, known for their complex structures and biological activity, remain a major source of GPCR-targeting agents. Recent advances in computer-aided drug design (CADD) have improved the discovery of GPCR ligands, including natural compounds, through both structure-based and ligand-based methods. These include molecular docking, de novo ligand design, pharmacophore modeling, 3D-QSAR, and AI-driven techniques such as machine learning and deep learning. This review explores how combining these approaches with post-docking techniques—like molecular dynamics simulations and binding energy calculations using MM/PB(GB)SA, thermodynamic integration (TI), and free energy perturbation (FEP)—can enhance lead optimization. It also highlights ongoing challenges in the field, such as receptor flexibility, ligand promiscuity, and the scarcity of high-resolution GPCR structures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledDrug DesignComputer-Aided DesignBiological ProductsLigandsHumansMolecular Docking SimulationMolecular Dynamics SimulationPharmacophoreQuantitative Structure-Activity RelationshipMachine LearningThermodynamicsDrug Discovery

Stichwörter der Autor:innen

AI-driven strategiesDeep learningGPCRsMachine learningNatural productsStructure-based and ligand-based approaches

Substanzen

LigandsReceptors, G-Protein-CoupledBiological Products

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Istanbul AREL University, Istanbul, 34537, Turkey. abdullahiibrahimuba@arel.edu.tr.

Zitieren

APA

Uba, A. I. (2025). Integrated Computer-Aided Drug Design: Advances in GPCR Natural Ligand Discovery. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-025-01902-3

Vancouver

Uba AI. Integrated Computer-Aided Drug Design: Advances in GPCR Natural Ligand Discovery. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-025-01902-3

BibTeX
@article{Uba2025,
  author = {Uba, Abdullahi Ibrahim},
  title = {Integrated Computer-Aided Drug Design: Advances in GPCR Natural Ligand Discovery},
  journal = {Cell Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1007/s12013-025-01902-3}
}
Kostenlos starten →